Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 13Tumor-Agnostic 12Gastrointestinal 11Thoracic 8Genitourinary 8Other hematologic neoplasm 6Breast 6NET 5Lymphoid 5Endocrine 5Dermatologic 5Head & Neck 4Plasma cell 3Other solid neoplasm 3CNS 3Sarcoma 2Myeloid 2Classical hematology 2

Conditions

Neoplasms 2Venous Thromboembolism 1Thrombosis 1Ovarian Neoplasms 1Fanconi Anemia, Complementation Group D1 1Breast Neoplasms 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Data Collection × Classical hematology × Clear all
NCT04846556 2023-10-11

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Centre Hospitalier Universitaire de Saint Etienne

Completed
300 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

M.D. Anderson Cancer Center

Completed
176 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡